These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29992882)

  • 41. Antiadherent activity of Schinus terebinthifolius and Croton urucurana extracts on in vitro biofilm formation of Candida albicans and Streptococcus mutans.
    Barbieri DS; Tonial F; Lopez PV; Sales Maia BH; Santos GD; Ribas MO; Glienke C; Vicente VA
    Arch Oral Biol; 2014 Sep; 59(9):887-96. PubMed ID: 24907518
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of Candida albicans virulence factors by novel levofloxacin derivatives.
    Shafreen RM; Muthamil S; Pandian SK
    Appl Microbiol Biotechnol; 2014 Aug; 98(15):6775-85. PubMed ID: 24723295
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Virulence modulation of Candida albicans biofilms by metal ions commonly released from orthodontic devices.
    Ronsani MM; Mores Rymovicz AU; Meira TM; Trindade Grégio AM; Guariza Filho O; Tanaka OM; Ribeiro Rosa EA
    Microb Pathog; 2011 Dec; 51(6):421-5. PubMed ID: 21925586
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel Sulfones with Antifungal Properties: Antifungal Activities and Interactions with Candida spp. Virulence Factors.
    Gizińska M; Staniszewska M; Ochal Z
    Mini Rev Med Chem; 2019; 19(1):12-21. PubMed ID: 30246638
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Temporal Profile of Biofilm Formation, Gene Expression and Virulence Analysis in Candida albicans Strains.
    de Barros PP; Rossoni RD; De Camargo Ribeiro F; Junqueira JC; Jorge AO
    Mycopathologia; 2017 Apr; 182(3-4):285-295. PubMed ID: 27830437
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Contribution of Aspartic Proteases in Candida Virulence. Protease Inhibitors against Candida Infections.
    Monika S; Małgorzata B; Zbigniew O
    Curr Protein Pept Sci; 2017; 18(10):1050-1062. PubMed ID: 27514853
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of quinoline based 1,2,3-triazole and its structural analogues on growth and virulence attributes of Candida albicans.
    Irfan M; Alam S; Manzoor N; Abid M
    PLoS One; 2017; 12(4):e0175710. PubMed ID: 28430797
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of tea polyphenols on Candida albicans: inhibition of biofilm formation and proteasome inactivation.
    Evensen NA; Braun PC
    Can J Microbiol; 2009 Sep; 55(9):1033-9. PubMed ID: 19898545
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biofilm inhibition by Cymbopogon citratus and Syzygium aromaticum essential oils in the strains of Candida albicans.
    Khan MS; Ahmad I
    J Ethnopharmacol; 2012 Mar; 140(2):416-23. PubMed ID: 22326355
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Candida albicans biofilm inhibition by synergistic action of terpenes and fluconazole.
    Pemmaraju SC; Pruthi PA; Prasad R; Pruthi V
    Indian J Exp Biol; 2013 Nov; 51(11):1032-7. PubMed ID: 24416942
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The correlation of virulence, pathogenicity, and itraconazole resistance with SAP activity in Candida albicans strains.
    Feng W; Yang J; Pan Y; Xi Z; Qiao Z; Ma Y
    Can J Microbiol; 2016 Feb; 62(2):173-8. PubMed ID: 26751517
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of magnolol and honokiol on adhesion, yeast-hyphal transition, and formation of biofilm by Candida albicans.
    Sun L; Liao K; Wang D
    PLoS One; 2015; 10(2):e0117695. PubMed ID: 25710475
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tramadol, an Opioid Receptor Agonist: An Inhibitor of Growth, Morphogenesis, and Biofilm Formation in the Human Pathogen, Candida albicans.
    Kathwate GH; Karuppayil SM
    Assay Drug Dev Technol; 2016 Dec; 14(10):567-572. PubMed ID: 27982704
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of silver nanoparticles on Candida albicans biofilms: an ultrastructural study.
    Lara HH; Romero-Urbina DG; Pierce C; Lopez-Ribot JL; Arellano-Jiménez MJ; Jose-Yacaman M
    J Nanobiotechnology; 2015 Dec; 13():91. PubMed ID: 26666378
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of tt-farnesol and myricetin on in vitro biofilm formed by Streptococcus mutans and Candida albicans.
    Rocha GR; Florez Salamanca EJ; de Barros AL; Lobo CIV; Klein MI
    BMC Complement Altern Med; 2018 Feb; 18(1):61. PubMed ID: 29444673
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mucins suppress virulence traits of Candida albicans.
    Kavanaugh NL; Zhang AQ; Nobile CJ; Johnson AD; Ribbeck K
    mBio; 2014 Nov; 5(6):e01911. PubMed ID: 25389175
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans.
    Cui J; Ren B; Tong Y; Dai H; Zhang L
    Virulence; 2015; 6(4):362-71. PubMed ID: 26048362
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Roles of RPS41 in Biofilm Formation, Virulence, and Hydrogen Peroxide Sensitivity in Candida albicans.
    Lu H; Xiong J; Shang Q; Jiang Y; Cao Y
    Curr Microbiol; 2016 Jun; 72(6):783-7. PubMed ID: 26952720
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Candida species isolated from different body sites and their antifungal susceptibility pattern: Cross-analysis of Candida albicans and Candida glabrata biofilms.
    Cataldi V; Di Campli E; Fazii P; Traini T; Cellini L; Di Giulio M
    Med Mycol; 2017 Aug; 55(6):624-634. PubMed ID: 27915303
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lipopeptides from Bacillus strain AR2 inhibits biofilm formation by Candida albicans.
    Rautela R; Singh AK; Shukla A; Cameotra SS
    Antonie Van Leeuwenhoek; 2014 May; 105(5):809-21. PubMed ID: 24623107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.